Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Pre-IPOs
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Moderna Inc. stock: mRNA pioneer's strategic pivot amid biotech sector challenges and vaccine market
Moderna Inc. continues to be a leading player in the biotechnology sector, leveraging its mRNA platform for innovation in vaccines and therapeutics. The company is strategically diversifying its pipeline beyond COVID-19 to include treatments for respiratory viruses, oncology, and rare diseases. Investors are closely monitoring its clinical trial progress, especially for its RSV vaccine and personalized cancer vaccine, and its financial resilience in a challenging biotech environment.